EIN: 273232063 · Tax Year 2022 · Source: IRS Form 990
| Metric | Amount |
|---|---|
| Total Revenue | $472K |
| Total Expenses | $380K |
| Net Income | $92K |
| Total Assets (End of Year) | $535K |
Cancer Genomics Consortium reported $472K in total revenue for the 2022 tax year, with $380K in total expenses and $535K in net assets.
Detailed spending breakdown data is not available for Cancer Genomics Consortium's 2022 filing.
This data comes from Cancer Genomics Consortium's IRS Form 990 filed for the 2022 tax year. Form 990 is a public document that all tax-exempt organizations must file annually with the IRS.
The IRS Form 990 is a public document that tax-exempt organizations must file annually. It provides detailed information about an organization's finances, governance, and activities. Key sections include revenue and expenses, compensation of officers, and program accomplishments.
All data shown on this page comes directly from Cancer Genomics Consortium's publicly available IRS Form 990 for the 2022 tax year. This information is provided for transparency and research purposes.